会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • AMINO COMPOUNDS AND ANGIOTENSIN IV RECEPTOR AGONISTS
    • 氨基化合物和血管紧张素Ⅱ受体激动剂
    • WO1998005624A1
    • 1998-02-12
    • PCT/JP1997002716
    • 1997-08-05
    • TAISHO PHARMACEUTICAL CO., LTD.SAGAMI CHEMICAL RESEARCH CENTERKOBORI, TakeoGODA, KenichiSUGIMOTO, KikuoOTA, TomomiTOMISAWA, Kazuyuki
    • TAISHO PHARMACEUTICAL CO., LTD.SAGAMI CHEMICAL RESEARCH CENTER
    • C07C211/13
    • C07D213/40C07C237/20C07D215/12
    • Amino compounds represented by general formula (1) or pharmaceutically acceptable salts thereof: (wherein X represents CH2NH or CONH; Y represents CH2NH or CONH, provided that X and Y do not represent CONH at the same time; Z represents CH=C(R )R , CH2CH(R )R or alkoxycarbonyl (wherein R and R independently represent each hydrogen or optionally substituted alkyl, aralkyl, aryl or heteroaryl); R represents hydrogen or optionally substituted lower alkyl, cycloalkyl, cycloalkyl-substituted alkyl, aralkyl or aryl; and R and R independently represent each optionally substituted lower alkyl or aralkyl); drugs composed of the amino compounds of general formula (1) or pharmaceutically acceptable salts thereof; and angiotensin receptor agonists containing the same as the active ingredient. These drugs are useful as remedies such as antagonists or agonists for various pathological states in which angiotensin IV participates, for example, accelerated renal blood flow, cerebral vasodilation, cell proliferation inhibition or hypermnesia.
    • 由通式(1)表示的氨基化合物或其药学上可接受的盐:(其中X表示CH 2 NH或CONH; Y表示CH 2 NH或CONH,条件是X和Y不同时表示CONH; Z表示CH = C R 5),CH 2 CH(R 4)R 5或烷氧基羰基(其中R 4和R 5独立地表示各个氢或任选取代的烷基,芳烷基,芳基或杂芳基); R R 1和R 3独立地代表各个任选被取代的低级烷基或芳烷基); R 2和R 3独立地表示任意取代的低级烷基或芳烷基。 由通式(1)的氨基化合物或其药学上可接受的盐组成的药物; 和含有与活性成分相同的血管紧张素受体激动剂。 这些药物可用作诸如血管紧张素IV参与的各种病理状态的拮抗剂或激动剂,例如加速肾血流量,脑血管扩张,细胞增殖抑制或高血症。